This is a Phase 2, open-label, multi-cohort study to evaluate the analgesic efficacy, safety,
and pharmacokinetics (PK) of a single, individualized dose of HTX-011 administered into the
surgical site as a monotherapy or with other medications to enhance analgesia in subjects
undergoing unilateral simple bunionectomy.